We like to think of heart attacks as the big vascular threat. Fair enough. But peripheral artery disease—PAD for short—is like the quiet cousin no one talks about until things go south. It affects up to 12 million Americans, though some estimates suggest the real number could be twice that, given how many cases go undetected. The arteries in the legs narrow. Blood flow drops. Pain creeps in when walking, then even at rest. Some people dismiss it as “just aging.” But that’s where it gets dangerous.
The Hidden Reach of Peripheral Artery Disease: More Common Than You Think
It’s not rare. In fact, about 1 in 5 people over 70 has PAD. Kick that down to age 50, and if you smoke or have diabetes, the odds still land at 1 in 10. The trouble? Over half don’t have obvious symptoms. No pain. No cramping. Just subtle fatigue in the legs that’s easy to shrug off. Which explains why diagnosis rates lag so far behind actual prevalence.
Here’s the catch: undiagnosed PAD isn’t benign. It’s a red flag for systemic atherosclerosis. The same plaque clogging leg arteries is likely narrowing those feeding the heart and brain. And that changes everything. A person with PAD is 6 to 7 times more likely to suffer a heart attack or stroke than someone without it. Yet, most primary care visits don’t include routine screening—like the ankle-brachial index test—unless symptoms scream for attention.
We’re far from it being standard, even though the test takes 10 minutes and costs under $50. Some clinics do it. Others rely on patient complaints. But people don’t complain when they’ve gradually stopped walking because “it just started to hurt.”
What Exactly Is Peripheral Artery Disease?
At its core, PAD is a circulation problem—usually in the legs—caused by atherosclerosis, the buildup of fatty deposits inside arteries. Oxygen-rich blood struggles to reach muscles during activity, leading to cramping, fatigue, or discomfort, typically in the calves. This is called claudication. But in severe cases, even resting hurts. Wounds won’t heal. Tissue dies. Amputation becomes a real risk.
The process is insidious. Plaque develops slowly. The body tries to compensate with collateral vessels—tiny detours around the blockage. These help, but only so much. Eventually, demand exceeds supply. You walk farther than usual, and your leg screams. That’s often the first real sign—except it’s not the first sign at all. The damage began years earlier.
Why Leg Arteries Are the Canary in the Coal Mine
Legs are a telltale. They’re far from the heart, so when systemic atherosclerosis hits, they show strain early. The ankle-brachial index (ABI)—a simple blood pressure comparison between arm and ankle—can detect flow issues long before symptoms appear. An ABI below 0.9 is abnormal. Below 0.5? That’s severe. And yet, most insurers won’t cover screening without symptoms or risk factors. Talk about locking the barn after the horse is gone.
It’s a bit like checking tire pressure only after the car starts pulling to one side. By then, you’re not preventing damage. You’re reacting to it.
Smoking: The Single Strongest Predictor of PAD Diagnosis
Forget cholesterol for a second. If you smoke, your risk skyrockets. Current smokers are up to 6 times more likely to develop PAD than non-smokers. Even former smokers stay at elevated risk—though quitting cuts it steadily over time. After 5 years, the risk drops by nearly half. After 10, it’s still higher than never-smokers, but closing in.
And that’s exactly where conventional wisdom falls short. Yes, smoking harms the lungs. But its vascular effects are just as brutal. Nicotine constricts arteries. Carbon monoxide reduces oxygen delivery. Inflammatory chemicals in smoke damage the endothelium—the delicate lining of blood vessels—making plaque formation easier. It’s not just a lung killer. It’s a circulation assassin.
I find this overrated: the idea that one pack a day “isn’t so bad.” Data shows otherwise. A 2019 study in Circulation followed over 20,000 adults for 15 years. Those smoking less than 10 cigarettes daily still faced a 2.3 times higher risk of PAD compared to non-smokers. That’s not marginal. That’s a serious hit.
How Long-Term Smoking Rewires Vascular Risk
The damage isn’t just structural. Smoking alters gene expression in blood vessels, promotes oxidative stress, and impairs the body’s ability to grow new microvessels (angiogenesis). In short: it sabotages the very mechanisms meant to compensate for blockages. So when plaque builds, the body can’t adapt as well. Claudication starts earlier. Progression is faster.
And here’s something people don’t think about enough—secondhand smoke. Long-term exposure at home or work raises PAD risk by 20% to 30%. Not as much as active smoking, but still significant. Especially in women, who may have heightened vascular sensitivity.
Diabetes and High Blood Pressure: The Silent Accelerators
Diabetes doubles the risk of PAD. High blood pressure? It increases it by 50%. Together? They’re a one-two punch. But the way they operate is different. Diabetes gums up small vessels through glycation end-products and nerve damage (neuropathy), which masks pain. You won’t feel the ache in your legs. So you keep walking on injured tissue. Ulcers form. Infections creep in. The first sign might be a non-healing wound—already stage 3 or 4 PAD.
High blood pressure, on the other hand, stresses arterial walls, promoting stiffness and plaque rupture. It’s less about metabolic havoc, more about mechanical wear. Combine it with diabetes, and you’ve got inflammation, oxidative damage, and endothelial dysfunction all feeding the same fire.
But here’s the twist: while diabetics are more likely to develop PAD, they’re less likely to report classic claudication. Which means they’re diagnosed later, often after complications arise. That’s not a minor detail. That’s a flaw in the diagnostic system.
Age and Gender: The Numbers Don’t Lie
PAD is rare under 40. After 50, risk climbs steadily. By 70, prevalence jumps to 15%–20%. Men are diagnosed more often than women—early on. But after age 80, women catch up. Why? Possibly due to hormonal shifts post-menopause and longer life expectancy. Yet women are underdiagnosed. Doctors are less likely to order ABI tests for female patients, even with identical risk profiles.
And that’s exactly where bias sneaks in. We assume heart disease is a “man’s problem.” But vascular disease doesn’t care about gender. It cares about risk exposure over time.
Cholesterol, Genetics, and Other Contributors
High LDL and low HDL matter—but less than you’d think. Cholesterol’s role in PAD is real, yet overshadowed by smoking and diabetes. Still, untreated familial hypercholesterolemia can lead to early-onset PAD, sometimes in the 40s. And that changes everything for young adults with a strong family history.
Genetics play a background role. If a first-degree relative had PAD, your risk increases by about 30%. Not as much as with coronary disease, but enough to warrant vigilance. Certain gene variants—like those affecting CRP or interleukin-6—are being studied for their inflammatory links to vascular degeneration.
But what about lifestyle factors beyond smoking? Obesity? Sedentary habits? They’re associated, yes—but often because they cluster with diabetes and hypertension. Standalone, their impact is modest. Physical inactivity, though, has a direct effect: it reduces collateral circulation development. Your body literally loses the ability to reroute blood flow when arteries clog.
PAD Risk: Smoking vs Diabetes vs Age – Which Matters Most?
Let’s be clear about this: smoking edges out everything. In head-to-head studies, it carries the highest population-attributable risk. But in an individual? It depends. A 60-year-old diabetic smoker with hypertension has a nearly guaranteed trajectory toward PAD—unless they intervene. A non-smoking 75-year-old with high blood pressure? Still at risk, but progression is slower.
Which explains why prevention strategies must be personalized. A 45-year-old smoker needs smoking cessation above all. A 60-year-old with type 2 diabetes? Glycemic control and foot checks are critical. One size doesn’t fit all. And because vascular damage is cumulative, the earlier you act, the more you preserve function.
Frequently Asked Questions
Can You Have PAD Without Symptoms?
Absolutely. Up to 50% of people with confirmed PAD report no classic leg pain. Instead, they might feel general fatigue or attribute limitations to aging. This is especially true in diabetics due to neuropathy. That’s why screening high-risk groups matters—even when they say they feel fine.
Is PAD Only a Leg Problem?
No. While leg arteries are most commonly affected, PAD can occur in arteries leading to the arms, kidneys, or stomach. Renal artery stenosis, for example, can cause hypertension and kidney dysfunction. Mesenteric ischemia leads to post-meal abdominal pain and weight loss. These forms are rarer but just as serious.
Does Treating PAD Prevent Heart Attacks?
Indirectly, yes. Aggressive management—quitting smoking, controlling blood pressure, statins, antiplatelet drugs—lowers cardiovascular risk across the board. PAD is a marker of systemic disease. Treat it, and you protect more than just the legs.
The Bottom Line
You’re most likely to be diagnosed with peripheral artery disease if you’re over 50, smoke, have diabetes, or live with high blood pressure. The overlap of these factors multiplies risk in ways that aren’t always obvious. And while age is non-modifiable, the big three—smoking, blood sugar, and blood pressure—are not. The data is still lacking on routine screening for all older adults, but experts agree: we’re missing too many cases. Some argue for universal ABI testing after 65. Others say target only high-risk groups. Honestly, it is unclear what’s scalable, but we know early detection saves limbs—and lives. My take? If you smoke or have diabetes, ask for the test. It’s quick. It’s cheap. And it might just change your trajectory. Because catching PAD early isn’t about fear. It’s about freedom—the freedom to walk without pain, to age without amputation, to live without the slow creep of vascular decline. And that’s worth fighting for.